Marvin Blanford
Plus aucun poste en cours
Profil
Dr. Blanford joined Kos in 1996 and is Senior Vice President, Drug Regulatory, Safety and Compliance.
In this capacity, Dr. Blanford oversees all regulatory, compliance and quality assurance functions for the Company.
Prior to Kos, Dr. Blanford was the Director of Clinical Research at Noven Pharmaceuticals from 1992 to 1995, and before that was Vice President of Health and Sciences Research, Inc., a company that performed clinical research for pharmaceutical firms.
Dr. Blanford also worked for Key Pharmaceuticals as a research manager from 1981 through 1984.
During Dr. Blanford's 20 year career, he has participated in the preparation and submission of many products to the FDA.
This experience is complemented by significant clinical research experience.
Dr. Blanford received a B.S.
in Pharmacy and a Pharm.D., both from the University of Kentucky.
Anciens postes connus de Marvin Blanford
Sociétés | Poste | Fin |
---|---|---|
KOS Pharmaceuticals, Inc.
KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Corporate Officer/Principal | - |
Formation de Marvin Blanford
University of Kentucky | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
Entreprise privées | 1 |
---|---|
KOS Pharmaceuticals, Inc.
KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Health Technology |